Legal Representation
Attorney
Robert B.G. Horowitz, Esq.
USPTO Deadlines 2 active
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-27) |
R.PRA | Aug 27, 2030 | 1877 days | Critical | No |
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2024-08-27) |
R.PRA | Aug 27, 2034 | 3338 days | Critical | No |
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-27)
on August 27, 2030
(1877 days)
Application History
22 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 2, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Aug 27, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Aug 27, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jun 11, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 11, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
May 22, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
May 9, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Oct 26, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 25, 2023 | ALIE | A | ASSIGNED TO LIE |
May 25, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
May 22, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
May 22, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
May 22, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN |
May 22, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
May 22, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
May 22, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
May 22, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
May 22, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 13, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Dec 12, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 24, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 042
Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Class 044
Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Additional Information
Design Mark
The mark consists of two swoosh designs. The top swoosh extends from the upper left to the lower right with an upward curve, and the bottom swoosh extends from the lower right curving upward to the middle left, with a downward curve. The upper curve has a gray edge with colored gradations to gray blue and blue in the middle of that curve. The bottom curve has gray for an outside edge with colored gradations to blue gray in the middle of that curve.
Color Claim
The color(s) gray, blue gray and blue is/are claimed as a feature of the mark.
Classification
International Classes
005
042
044